{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T20:45:36Z","timestamp":1781901936778,"version":"3.54.5"},"reference-count":43,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["EY020617"],"award-info":[{"award-number":["EY020617"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30EY022589"],"award-info":[{"award-number":["P30EY022589"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.actbio.2014.04.024","type":"journal-article","created":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T23:31:29Z","timestamp":1398987089000},"page":"3505-3512","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Porous silicon oxide\u2013PLGA composite microspheres for sustained ocular delivery of daunorubicin"],"prefix":"10.1016","volume":"10","author":[{"given":"Kaihui","family":"Nan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feiyan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiyuan","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William R.","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Sailor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingyun","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.actbio.2014.04.024_b0005","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0039-6257(98)00023-X","article-title":"Proliferative vitreoretinopathy: an overview","volume":"43","author":"Pastor","year":"1998","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/j.actbio.2014.04.024_b0010","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S0002-9394(98)00115-9","article-title":"Adjunctive daunorubicin in the treatment of proliferative vitreoretinopathy: results of a multicenter clinical trial. Daunomycin Study Group","volume":"126","author":"Wiedemann","year":"1998","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.actbio.2014.04.024_b0015","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3928\/1542-8877-20030701-05","article-title":"Efficacy of daunorubicin encapsulated in liposome for the treatment of proliferative vitreoretinopathy","volume":"34","author":"Shinohara","year":"2003","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"10.1016\/j.actbio.2014.04.024_b0020","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1007\/BF00166311","article-title":"Daunorubicin treatment in a refined experimental model of proliferative vitreoretinopathy","volume":"229","author":"Khawly","year":"1991","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.actbio.2014.04.024_b0025","first-page":"2160","article-title":"The effect of combined daunorubicin and triamcinolone acetonide treatment on a refined experimental model of proliferative vitreoretinopathy","volume":"33","author":"Chen","year":"1992","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.actbio.2014.04.024_b0030","first-page":"719","article-title":"Daunomycin in the treatment of experimental proliferative vitreoretinopathy. Effective doses in vitro and in vivo","volume":"26","author":"Wiedemann","year":"1985","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.actbio.2014.04.024_b0035","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/BF02134142","article-title":"Daunomycin in the treatment of experimental proliferative vitreoretinopathy: retinal toxicity of intravitreal daunomycin in the rabbit","volume":"221","author":"Santana","year":"1984","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.actbio.2014.04.024_b0040","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1136\/bjo.79.10.874","article-title":"Onset and recurrence of proliferative vitreoretinopathy in various vitreoretinal disease","volume":"79","author":"Mietz","year":"1995","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.actbio.2014.04.024_b0045","doi-asserted-by":"crossref","first-page":"6208","DOI":"10.1016\/j.actbio.2012.12.010","article-title":"Engineering porous silicon nanostructures as tunable carriers for mitoxantrone dihydrochloride","volume":"9","author":"Tzur-Balter","year":"2013","journal-title":"Acta Biomater"},{"key":"10.1016\/j.actbio.2014.04.024_b0050","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1167\/iovs.12-11172","article-title":"Oxidized porous silicon particles covalently grafted with daunorubicin as a sustained intraocular drug delivery system","volume":"54","author":"Chhablani","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/j.actbio.2014.04.024_b0055","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/pssa.200306519","article-title":"Dissolution of different forms of partially porous silicon wafers under simulated physiological conditions","volume":"197","author":"Anderson","year":"2003","journal-title":"Phys Status Solidi A"},{"key":"10.1016\/j.actbio.2014.04.024_b0060","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.exer.2013.09.001","article-title":"Ocular silicon distribution and clearance following intravitreal injection of porous silicon microparticles","volume":"116","author":"Nieto","year":"2013","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.actbio.2014.04.024_b0065","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1002\/1521-4095(200006)12:12<859::AID-ADMA859>3.0.CO;2-0","article-title":"Chemical and biological applications of porous silicon technology","volume":"12","author":"Stewart","year":"2000","journal-title":"Adv Mater"},{"key":"10.1016\/j.actbio.2014.04.024_b0070","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1089\/jop.2012.0205","article-title":"Hydrosilylated porous silicon particles function as an intravitreal drug delivery system for daunorubicin","volume":"29","author":"Hartmann","year":"2013","journal-title":"J Ocul Pharmacol Ther"},{"key":"10.1016\/j.actbio.2014.04.024_b0075","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1136\/bjo.2007.133587","article-title":"Intravitreal properties of porous silicon photonic crystals: a potential self-reporting intraocular drug-delivery vehicle","volume":"92","author":"Cheng","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.actbio.2014.04.024_b0080","doi-asserted-by":"crossref","first-page":"11264","DOI":"10.1021\/la048105t","article-title":"Engineering the chemistry and nanostructure of porous silicon Fabry\u2013P\u00e9rot films for loading and release of a steroid","volume":"20","author":"Anglin","year":"2004","journal-title":"Langmuir"},{"key":"10.1016\/j.actbio.2014.04.024_b0085","doi-asserted-by":"crossref","first-page":"4168","DOI":"10.1002\/adfm.201000907","article-title":"Sustained release of a monoclonal antibody from electrochemically prepared mesoporous silicon oxide","volume":"20","author":"Andrew","year":"2010","journal-title":"Adv Funct Mater"},{"key":"10.1016\/j.actbio.2014.04.024_b0090","doi-asserted-by":"crossref","first-page":"4538","DOI":"10.1016\/j.biomaterials.2006.04.015","article-title":"Evaluation of mammalian cell adhesion on surface-modified porous silicon","volume":"27","author":"Low","year":"2006","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2014.04.024_b0095","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.addr.2008.03.017","article-title":"Porous silicon in drug delivery devices and materials","volume":"60","author":"Anglin","year":"2008","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.actbio.2014.04.024_b0100","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/j.biomaterials.2010.11.013","article-title":"Real-time monitoring of sustained drug release using the optical properties of porous silicon photonic crystal particles","volume":"32","author":"Wu","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2014.04.024_b0105","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jconrel.2007.01.008","article-title":"Development and evaluation of novel biodegradable microspheres based on poly(d, l-lactide-co-glycolide) and poly(epsilon-caprolactone) for controlled delivery of doxycycline in the treatment of human periodontal pocket: in vitro and in vivo studies","volume":"119","author":"Mundargi","year":"2007","journal-title":"J Control Release"},{"key":"10.1016\/j.actbio.2014.04.024_b0110","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1021\/mp034002c","article-title":"Sustained cytoplasmic delivery of drugs with intracellular receptors using biodegradable nanoparticles","volume":"1","author":"Panyam","year":"2004","journal-title":"Mol Pharm"},{"key":"10.1016\/j.actbio.2014.04.024_b0115","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1039\/b305903k","article-title":"Surface-initiated, ring-opening polymerization of p-dioxanone from gold and silicon oxide surfaces","volume":"13","author":"Yoon","year":"2003","journal-title":"J Mater Chem"},{"key":"10.1016\/j.actbio.2014.04.024_b0120","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/j.biomaterials.2008.12.013","article-title":"PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery","volume":"30","author":"Chan","year":"2009","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2014.04.024_b0125","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.jconrel.2009.10.010","article-title":"Spray drying of siRNA-containing PLGA nanoparticles intended for inhalation","volume":"142","author":"Jensen","year":"2010","journal-title":"J Control Release"},{"key":"10.1016\/j.actbio.2014.04.024_b0130","doi-asserted-by":"crossref","DOI":"10.1088\/1748-6041\/5\/6\/065002","article-title":"A modified double-emulsion method for the preparation of daunorubicin-loaded polymeric nanoparticle with enhanced in vitro anti-tumor activity","volume":"5","author":"Liu","year":"2010","journal-title":"Biomed Mater"},{"key":"10.1016\/j.actbio.2014.04.024_b0135","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/adfm.201100403","article-title":"Mesoporous silicon\u2013PLGA composite microspheres for the double controlled release of biomolecules for orthopedic tissue engineering","volume":"22","author":"Fan","year":"2012","journal-title":"Adv Funct Mater"},{"key":"10.1016\/j.actbio.2014.04.024_b0140","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jconrel.2008.02.012","article-title":"Controlled release carrier of BSA made by W\/O\/W emulsion method containing PLGA and hydroxyapatite","volume":"128","author":"Ho","year":"2008","journal-title":"J Control Release"},{"key":"10.1016\/j.actbio.2014.04.024_b0145","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1002\/jbm.a.34507","article-title":"Real-time cellular analysis as a novel approach for in vitro cytotoxicity testing of medical device extracts","volume":"101","author":"Garcia","year":"2013","journal-title":"J Biomed Mater Res Part A"},{"key":"10.1016\/j.actbio.2014.04.024_b0150","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jconrel.2004.04.023","article-title":"PLGA\/mesoporous silica hybrid structure for controlled drug release","volume":"98","author":"Xue","year":"2004","journal-title":"J Control Release"},{"key":"10.1016\/j.actbio.2014.04.024_b0155","doi-asserted-by":"crossref","DOI":"10.1038\/am.2013.26","article-title":"The influence of additives in modulating drug delivery and degradation of PLGA thin films","volume":"5","author":"Huang","year":"2013","journal-title":"Npg Asia Mater"},{"key":"10.1016\/j.actbio.2014.04.024_b0160","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.jconrel.2013.05.034","article-title":"The effect of lauryl capping group on protein release and degradation of poly(d, l-lactic-co-glycolic acid) particles","volume":"172","author":"Samadi","year":"2013","journal-title":"J Control Release"},{"key":"10.1016\/j.actbio.2014.04.024_b0165","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1016\/j.biomaterials.2013.02.015","article-title":"Mechanism of drug release from double-walled PDLLA(PLGA) microspheres","volume":"34","author":"Xu","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2014.04.024_b0170","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ejpb.2012.11.006","article-title":"Optimization of encapsulation of a synthetic long peptide in PLGA nanoparticles: low-burst release is crucial for efficient CD8(+) T cell activation","volume":"83","author":"Silva","year":"2013","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.actbio.2014.04.024_b0175","doi-asserted-by":"crossref","first-page":"722","DOI":"10.2174\/15672018113109990002","article-title":"In vitro drug release behavior, mechanism and antimicrobial activity of rifampicin loaded low molecular weight PLGA\u2013PEG\u2013PLGA triblock copolymeric nanospheres","volume":"10","author":"Gajendiran","year":"2013","journal-title":"Curr Drug Deliv"},{"key":"10.1016\/j.actbio.2014.04.024_b0180","doi-asserted-by":"crossref","first-page":"66","DOI":"10.3109\/10837450.2010.513989","article-title":"Reduction in burst release after coating poly(d, l-lactide-co-glycolide) (PLGA) microparticles with a drug-free PLGA layer","volume":"17","author":"Ahmed","year":"2012","journal-title":"Pharm Dev Technol"},{"key":"10.1016\/j.actbio.2014.04.024_b0185","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/jbm.b.33007","article-title":"Synthesis of mesoporous silica nanoparticle-encapsulated alginate microparticles for sustained release and targeting therapy","volume":"102","author":"Liao","year":"2014","journal-title":"J Biomed Mater Res B"},{"key":"10.1016\/j.actbio.2014.04.024_b0190","first-page":"4521","article-title":"Development of PLGA-based itraconazole injectable nanospheres for sustained release","volume":"8","author":"Bian","year":"2013","journal-title":"Int J Nanomed"},{"key":"10.1016\/j.actbio.2014.04.024_b0195","doi-asserted-by":"crossref","first-page":"811","DOI":"10.4155\/tde.13.52","article-title":"Recent advances in porous silicon technology for drug delivery","volume":"4","author":"Barnes","year":"2013","journal-title":"Ther Deliv"},{"key":"10.1016\/j.actbio.2014.04.024_b0200","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3109\/02652048.2012.717114","article-title":"Relationship between the solution thermodynamic properties of naproxen in organic solvents and its release profiles from PLGA microspheres","volume":"30","author":"Aragon","year":"2013","journal-title":"J Microencapsul"},{"key":"10.1016\/j.actbio.2014.04.024_b0205","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/j.ejpb.2008.07.008","article-title":"Reduction in burst release of PLGA microparticles by incorporation into cubic phase-forming systems","volume":"70","author":"Ahmed","year":"2008","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.actbio.2014.04.024_b0210","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ijpharm.2006.10.036","article-title":"Effect of WOW process parameters on morphology and burst release of FITC-dextran loaded PLGA microspheres","volume":"334","author":"Mao","year":"2007","journal-title":"Int J Pharm"},{"key":"10.1016\/j.actbio.2014.04.024_b0215","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.jconrel.2005.07.001","article-title":"Preparation and characterization of melittin-loaded poly (dl-lactic acid) or poly (dl-lactic-co-glycolic acid) microspheres made by the double emulsion method","volume":"107","author":"Cui","year":"2005","journal-title":"J Control Release"}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706114001937?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706114001937?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T07:36:45Z","timestamp":1777621005000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1742706114001937"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":43,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S1742706114001937"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2014.04.024","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Porous silicon oxide\u2013PLGA composite microspheres for sustained ocular delivery of daunorubicin","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2014.04.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}